Save time and money with
|
|
|||
Major World Markets for Stents and The Economics of Drug-Eluting Technology
SummarySince the arrival of drug-eluting (called drug-eluding by some) technology a few years ago with the promise of reducing restenosis, questions abound surrounding the future of the stent market: After numerous clinical studies and mixed cost-effectiveness results, how is drug-eluding technology expected to peform in the future? What can companies do to best market this technology in the healthcare system of the US and 6 other major world markets? What are the market trends to watch that will determine growth in this field in the coming years? What companies have already established a leadership position in stents and what do start ups have to do to join them?
Major World Markets for Stents and The Economics of Drug Eluding Technology, written by Kalorama
Analyst Dr. Kenneth Krul, takes a hard look at these questions with
economic analysis unmatched by any resource. The field of drug-eluting
stents remains an exciting technological innovation that will be a major
part of cardiovascular intervention technologies over the next ten
years. This report provides a complete market assessment for coronary
stents broadly, with emphasis on the economics of drug-eluting stents. |
|
|||